|05/09/13||CareFusion Reports Third Quarter Fiscal 2013 Results|
|- Revenue of $901 million in line with company expectations
- GAAP operating margins of 15 percent increased to 22.3 percent on an adjusted basis
- GAAP diluted earnings per share (EPS) from continuing operations totaled $0.37, including the impact of a previously disclosed reserve for an expected government settlement
- Adjusted diluted EPS from continuing operations increased 5 percent to $0.59
SAN DIEGO, May 9, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global m... |
|04/25/13||CareFusion Reaches Agreement In Principle On Previously Disclosed Matter With Federal Government|
|SAN DIEGO, April 25, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced an agreement in principle to resolve previously disclosed government investigations related to prior sales and marketing practices for its ChloraPrep® skin preparation product and its relationships with health care professionals.
The company expects to pay the government approximately $41 million to resolve the allegations. CareFusion will record the charge in... |
|04/15/13||CareFusion to Report Third Quarter Fiscal 2013 Results on May 9|
|SAN DIEGO, April 15, 2013 /PRNewswire/ -- CareFusion Corporation (NYSE: CFN) today announced plans to release third quarter fiscal 2013 results on Thursday, May 9, following the close of trading on the New York Stock Exchange.
The company will host a conference call on May 9 at 2 p.m. PDT (5 p.m. EDT) to discuss the results for its third quarter fiscal 2013, ended on March 31, 2013. To access the call, visit the Investors page at www.carefusion.com. Log on at least 15 minutes before the ca... |
|03/06/13||CareFusion Announces Proposed Offering Of $300 Million Senior Notes|
|SAN DIEGO, March 6, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN) today announced a private offering of $300 million aggregate principal amount of senior notes, the net proceeds of which the company intends to use for general corporate purposes.
The notes will be senior unsecured obligations of the company, offered solely to qualified institutional buyers in the United States in accordance with Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain ... |